[go: up one dir, main page]

DE69009748D1 - Fgf enthaltende stabilisierte zubereitungen. - Google Patents

Fgf enthaltende stabilisierte zubereitungen.

Info

Publication number
DE69009748D1
DE69009748D1 DE69009748T DE69009748T DE69009748D1 DE 69009748 D1 DE69009748 D1 DE 69009748D1 DE 69009748 T DE69009748 T DE 69009748T DE 69009748 T DE69009748 T DE 69009748T DE 69009748 D1 DE69009748 D1 DE 69009748D1
Authority
DE
Germany
Prior art keywords
tissular
fgfs
applications
preparations containing
fgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69009748T
Other languages
English (en)
Other versions
DE69009748T2 (de
Inventor
Denis Barritault
Jacqueline Jozefonvicz
Faouzi Slaoui
Michele Tardieu
Jean-Pierre Caruelle
Jose Courty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPEUTIQUES SUBSTITUTIVES V
Original Assignee
THERAPEUTIQUES SUBSTITUTIVES V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69009748(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by THERAPEUTIQUES SUBSTITUTIVES V filed Critical THERAPEUTIQUES SUBSTITUTIVES V
Publication of DE69009748D1 publication Critical patent/DE69009748D1/de
Application granted granted Critical
Publication of DE69009748T2 publication Critical patent/DE69009748T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69009748T 1989-03-09 1990-03-09 Fgf enthaltende stabilisierte zubereitungen. Expired - Lifetime DE69009748T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903086A FR2644066B1 (fr) 1989-03-09 1989-03-09 Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques
PCT/FR1990/000164 WO1990010456A1 (fr) 1989-03-09 1990-03-09 Compositions stabilisees a base de fgf

Publications (2)

Publication Number Publication Date
DE69009748D1 true DE69009748D1 (de) 1994-07-14
DE69009748T2 DE69009748T2 (de) 1994-09-22

Family

ID=9379523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69009748T Expired - Lifetime DE69009748T2 (de) 1989-03-09 1990-03-09 Fgf enthaltende stabilisierte zubereitungen.

Country Status (10)

Country Link
EP (1) EP0462194B1 (de)
JP (1) JP3236916B2 (de)
AT (1) ATE106743T1 (de)
AU (1) AU5283890A (de)
CA (1) CA2048638C (de)
DE (1) DE69009748T2 (de)
DK (1) DK0462194T3 (de)
ES (1) ES2057544T3 (de)
FR (1) FR2644066B1 (de)
WO (1) WO1990010456A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
FR2718026B1 (fr) * 1994-03-30 1997-01-17 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des muscles.
FR2718025B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
FR2718024B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2718023B1 (fr) * 1994-03-30 1996-08-14 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
FR2772382B1 (fr) * 1997-12-11 2000-03-03 Solutions Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
IL141688A0 (en) * 1998-09-04 2002-03-10 Scios Inc Hydrogel compositions for the controlled release administration of growth factors
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
LT2280720T (lt) 2008-03-27 2019-07-25 Purdue Research Foundation Kolageną surišantys sintetiniai peptidoglikanai, jų paruošimas ir naudojimo būdai
CN106117318A (zh) 2011-05-24 2016-11-16 塞米克Ip有限公司 结合透明质酸的合成肽聚糖、制备和使用方法
MX2015012608A (es) 2013-03-15 2016-07-06 Symic Biomedical Inc Peptidos sinteticos de union a matriz extracelular.
WO2015164822A1 (en) 2014-04-25 2015-10-29 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
US11529424B2 (en) 2017-07-07 2022-12-20 Symic Holdings, Inc. Synthetic bioconjugates
US11596399B2 (en) 2021-06-23 2023-03-07 Covidien Lp Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf

Also Published As

Publication number Publication date
ATE106743T1 (de) 1994-06-15
FR2644066A1 (fr) 1990-09-14
CA2048638A1 (en) 1990-09-10
CA2048638C (en) 2002-06-11
DE69009748T2 (de) 1994-09-22
EP0462194B1 (de) 1994-06-08
JPH04505756A (ja) 1992-10-08
EP0462194A1 (de) 1991-12-27
FR2644066B1 (fr) 1994-05-13
JP3236916B2 (ja) 2001-12-10
WO1990010456A1 (fr) 1990-09-20
AU5283890A (en) 1990-10-09
ES2057544T3 (es) 1994-10-16
DK0462194T3 (da) 1994-09-19

Similar Documents

Publication Publication Date Title
ATE106743T1 (de) Fgf enthaltende stabilisierte zubereitungen.
DE3874813D1 (de) Zusammensetzung zur behandlung der haut.
EP0202298A4 (de) Heilmittel für wunden.
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
FI880845A0 (fi) bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
ES2149347T3 (es) Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
8364 No opposition during term of opposition